[go: up one dir, main page]

AR038326A1 - Antibacterianos feniloxazolidinonas sustituidos con heterociclicos biciclicos y composiciones relacionadas y metodos - Google Patents

Antibacterianos feniloxazolidinonas sustituidos con heterociclicos biciclicos y composiciones relacionadas y metodos

Info

Publication number
AR038326A1
AR038326A1 ARP030100243A ARP030100243A AR038326A1 AR 038326 A1 AR038326 A1 AR 038326A1 AR P030100243 A ARP030100243 A AR P030100243A AR P030100243 A ARP030100243 A AR P030100243A AR 038326 A1 AR038326 A1 AR 038326A1
Authority
AR
Argentina
Prior art keywords
alkyl
carbon atoms
group
amino
straight
Prior art date
Application number
ARP030100243A
Other languages
English (en)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of AR038326A1 publication Critical patent/AR038326A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Un compuesto de fórmula (1) en la cual: R se selecciona entre el grupo que consiste en OH, O-Arilo, O-Heteroarilo, N3, OR', OSO2R'', -NR'''R'''', o un compuesto de fórmula (2) en la cual: (i) R' es acilo de cadena recta o ramificada que tiene hasta 6 átomos de carbono de bencilo; (ii) R'' es alquilo de cadena recta o ramificado, que tiene hasta 5 átomos de carbono, fenilo o tolilo; y (iii) R''' y R'''' se seleccionan independientemente entre el grupo que consiste en H, cicloalquilo que tiene de 3 a 6 átomos de carbono, fenilo o terbutoxicarbonilo, fluoreniloxicarbonilo, benciloxicarbonilo, alquilo de cadena recta o ramificado que tiene hasta 6 átomos de carbono que es optativamente sustituido por ciano o alcoxicarbonilo que tiene hasta 4 átomos de carbono, -CO2-R1, -CO-R1, -CS-R1, y -SO2R4, en donde R1 se selecciona entre el grupo que consiste en H, cicloaquilo que tiene de 3 a 6 átomos de carbono, trifluorometilo o fenilo, bencilo o acilo con hasta 5 átomos de carbono, alquilo de cadena recta o ramificado con hasta 6 átomos de carbono, dicho alquilo optativamente sustituido por alcoxicarbonilo de cadena recta o ramificado con hasta 5 átomos de carbono, OH, ciano, hasta 3 átomos de halógeno, y -NR5R6 en donde R5 y R6 son idénticos o diferentes y se seleccionan entre H, fenilo o alquilo, de cadena recta o ramificado con hasta 4 átomos de carbono; R4 se selecciona entre alquilo de cadena recta o ramificado con hasta 4 átomos de carbono o fenilo y; R4a es CN, COR4c, COOR4c, CONHR4c, CO-NR4c, R4d, SO2R4c, ó NO2; R4b es H, alquilo, OR4c, SR4c, amino, NHR4c, NR4c, R4d; R4c y R4d se seleccionan independientemente entre H, alquilo, arilo o en el caso de cualquier grupo NR4cR4d, R4c y R4d tomados en conjunto con el átomo de nitrógeno al cual están unidos forman un grupo pirrolidinilo, piperidinilo o morfolinilo insustituido o sustituido; X es 0 a 4 miembros seleccionados independientemente entre el grupo que consiste en halógeno, OH, nitro, alcoxi C1-8, alquil-amino C1-8, di(alquil-C1-8)amino, carboxi, alcoxicarbonilo, alquil C1-8-CO-O-, alquil C1-8-CO-NH-, carboxamida, CN, amina, cicloalquilo C3-6, alquilo C1-8 sustituido optativamente con uno o más miembros seleccionados entre el grupo que consiste en F, Cl, OH; e Y es un radical de las fórmulas (3) ó (4): en donde R5, R6, R7 y R8 son cada uno en forma independiente H, alquilo, CN, nitro, alquilo C1-8, halo-alquilo-C1-8, formilo, carboxi, alcoxicarbonilo, carboxamida o R5 y R6 y/o R7 y R8 juntos forman un grupo oxo; R9 y R10 son individualmente en forma independiente H, halógeno, alquilo, OH, CN, nitro, alquilo C1-8, halo-alquilo-C1-8, alcoxilo C1-8, amino, alquil-C1-8-amino, di(alquil-C1-8)amino, formilo, carboxi, alcoxicarbonilo, alquil-C1-8-CO-O, alquil-C1-8-CO-NH-, carboxamida o amina; Q es un anillo de fenilo fusionado o un anillo heteroaromático de cinco o seis miembros con uno a cuatro miembros seleccionados entre el grupo que consiste en S, O y N; Z es halógeno, alquilo, alquilo sustituido, arilo, arilo sustituido, heteroarilo, heteroarilo sustituido, CN, CHO, COalquilo, amino, alcoxi, HNCO-(alquilo-C1-8), alilo, propargilo, alenilo o N-alquiltiocarbamoílo; y m es 0 ó 1, y sus sales y ésteres farmacéuticamente aceptables.
ARP030100243A 2002-01-28 2003-01-28 Antibacterianos feniloxazolidinonas sustituidos con heterociclicos biciclicos y composiciones relacionadas y metodos AR038326A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/058,841 US6608081B2 (en) 1999-08-12 2002-01-28 Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods

Publications (1)

Publication Number Publication Date
AR038326A1 true AR038326A1 (es) 2005-01-12

Family

ID=27658242

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100243A AR038326A1 (es) 2002-01-28 2003-01-28 Antibacterianos feniloxazolidinonas sustituidos con heterociclicos biciclicos y composiciones relacionadas y metodos

Country Status (14)

Country Link
US (2) US6608081B2 (es)
EP (1) EP1470123A1 (es)
JP (1) JP2005520815A (es)
KR (1) KR20040085167A (es)
CN (1) CN1642949A (es)
AR (1) AR038326A1 (es)
BR (1) BR0307259A (es)
CA (1) CA2474718A1 (es)
MX (1) MXPA04007240A (es)
MY (1) MY134701A (es)
PL (1) PL371527A1 (es)
RU (1) RU2004123097A (es)
TW (1) TW200307679A (es)
WO (1) WO2003064415A1 (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608081B2 (en) 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
US6897230B2 (en) * 2001-04-17 2005-05-24 Kyorin Pharmaceutical Co., Ltd. Bicyclo[3/1/0] hexane containing oxazolidinone antibiotics and derivatives thereof
WO2005005420A1 (en) * 2003-07-02 2005-01-20 Merck & Co., Inc. Cyclopropyl group substituted oyazolidinone antibiotics and derivatives thereof
US20070293493A1 (en) * 2003-07-02 2007-12-20 Milton Hammond Oxazolidinone antibiotics and derivatives thereof
WO2005005398A2 (en) * 2003-07-02 2005-01-20 Merck & Co., Inc. Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
EP1656357A1 (en) * 2003-07-02 2006-05-17 Merck & Co., Inc. Oxazolidinone antibiotics and derivatives thereof
US7687627B2 (en) * 2003-09-08 2010-03-30 Wockhardt Limited Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
DOP2006000268A (es) * 2005-12-22 2007-07-31 Pfizer Prod Inc Agentes antibacterianos
US8124623B2 (en) 2006-11-10 2012-02-28 Actelion Pharmaceuticals Ltd. 5-hydroxymethyl-oxazolidin-2-one-derivatives and their uses as antibacterials
JP4484965B2 (ja) * 2006-11-10 2010-06-16 アクテリオン ファーマシューティカルズ リミテッド 5−ヒドロキシメチル−オキサゾリジン−2−オン誘導体
CN101084901B (zh) * 2007-06-22 2011-12-21 复旦大学 一种葡萄球菌抑制剂
AU2009318783A1 (en) 2008-11-20 2011-06-23 Panacea Biotec Ltd. Novel antimicrobials
JP5696142B2 (ja) 2009-06-26 2015-04-08 パナセア バイオテック リミテッド 新規アザビシクロヘキサン類
US9487545B2 (en) 2011-09-30 2016-11-08 Xuanzhu Pharma Co., Ltd. Fused ring-containing oxazolidinones antibiotics
JP6162704B2 (ja) * 2011-10-11 2017-07-12 カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ オキサゾリジノン誘導体のシラアナログ及びその合成
US10674982B2 (en) 2015-08-06 2020-06-09 Covidien Lp System and method for local three dimensional volume reconstruction using a standard fluoroscope
US10716525B2 (en) 2015-08-06 2020-07-21 Covidien Lp System and method for navigating to target and performing procedure on target utilizing fluoroscopic-based local three dimensional volume reconstruction
US10702226B2 (en) 2015-08-06 2020-07-07 Covidien Lp System and method for local three dimensional volume reconstruction using a standard fluoroscope
CN106083994B (zh) * 2016-04-18 2019-12-06 南京曼杰生物科技有限公司 取代的噁唑烷酮水溶性衍生物及其应用
JP6821716B2 (ja) * 2016-06-29 2021-01-27 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft B型肝炎ウイルス感染の処置および予防のための新規のジヒドロピロロピリミジン
US10087171B2 (en) 2016-12-19 2018-10-02 Actelion Pharmaceuticals Ltd Crystalline forms of cadazolid
US11529190B2 (en) 2017-01-30 2022-12-20 Covidien Lp Enhanced ablation and visualization techniques for percutaneous surgical procedures
US11793579B2 (en) 2017-02-22 2023-10-24 Covidien Lp Integration of multiple data sources for localization and navigation
US10699448B2 (en) 2017-06-29 2020-06-30 Covidien Lp System and method for identifying, marking and navigating to a target using real time two dimensional fluoroscopic data
WO2019075074A1 (en) 2017-10-10 2019-04-18 Covidien Lp SYSTEM AND METHOD FOR IDENTIFICATION AND MARKING OF A TARGET IN A THREE-DIMENSIONAL FLUOROSCOPIC RECONSTRUCTION
US11364004B2 (en) 2018-02-08 2022-06-21 Covidien Lp System and method for pose estimation of an imaging device and for determining the location of a medical device with respect to a target
KR102777328B1 (ko) 2018-07-25 2025-03-10 자이두스 라이프사이언시즈 리미티드 포유류 감염 치료를 위한 신규 화합물
US11705238B2 (en) 2018-07-26 2023-07-18 Covidien Lp Systems and methods for providing assistance during surgery
US11877806B2 (en) 2018-12-06 2024-01-23 Covidien Lp Deformable registration of computer-generated airway models to airway trees
US11801113B2 (en) 2018-12-13 2023-10-31 Covidien Lp Thoracic imaging, distance measuring, and notification system and method
US11617493B2 (en) 2018-12-13 2023-04-04 Covidien Lp Thoracic imaging, distance measuring, surgical awareness, and notification system and method
US11357593B2 (en) 2019-01-10 2022-06-14 Covidien Lp Endoscopic imaging with augmented parallax
US11625825B2 (en) 2019-01-30 2023-04-11 Covidien Lp Method for displaying tumor location within endoscopic images
US11744643B2 (en) 2019-02-04 2023-09-05 Covidien Lp Systems and methods facilitating pre-operative prediction of post-operative tissue function
WO2020234636A1 (en) 2019-05-17 2020-11-26 Cadila Healthcare Limited Novel compounds for the treatment of mammalian infections
US11627924B2 (en) 2019-09-24 2023-04-18 Covidien Lp Systems and methods for image-guided navigation of percutaneously-inserted devices
US12102298B2 (en) 2019-12-10 2024-10-01 Covidien Lp Lymphatic system tracking
US12161309B2 (en) 2020-09-24 2024-12-10 Covidien Lp Articulating mechanism for the laparoscopic ablation device for blunt dissection

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3391150A (en) 1965-12-17 1968-07-02 Merck & Co Inc Thiadiazole compounds and processes for preparing same
WO1989005643A1 (en) 1987-12-18 1989-06-29 Pfizer Inc. Heterocyclic-substituted quinoline-carboxylic acids
DE4121214A1 (de) 1991-06-27 1993-01-14 Bayer Ag 7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
AU659501B2 (en) 1991-10-23 1995-05-18 Biota Scientific Management Pty Ltd Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
KR100257418B1 (ko) 1991-11-01 2000-05-15 로렌스 티. 마이젠헬더 치환된 아릴-및 헤테로아릴-페닐옥사졸리디논
US5289157A (en) 1991-12-23 1994-02-22 Vitafit International, Inc. Medicine reminder and storage device
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
EP0788498B1 (en) 1994-10-26 2001-08-16 PHARMACIA & UPJOHN COMPANY Phenyloxazolidinone antimicrobials
US5952324A (en) 1994-11-15 1999-09-14 Pharmacia & Upjohn Company Bicyclic oxazine and thiazine oxazolidinone antibacterials
BR9607017A (pt) 1995-02-03 1997-10-28 Upjohn Co Composto e uso do mesmo
US6124334A (en) 1995-02-03 2000-09-26 Pharmacia & Upjohn Company Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
CA2218088A1 (en) 1995-05-11 1996-11-14 Pharmacia & Upjohn Company Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones
MX9703040A (es) 1995-09-12 1997-07-31 Upjohn Co Antimicrobianos de feniloxazolidinona.
DE19601264A1 (de) 1996-01-16 1997-07-17 Bayer Ag Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone
DE19604223A1 (de) 1996-02-06 1997-08-07 Bayer Ag Neue substituierte Oxazolidinone
CZ298060B6 (cs) 1996-04-11 2007-06-06 Pharmacia & Upjohn Company Zpusob prípravy oxazolidinonu
CN1138765C (zh) 1997-05-30 2004-02-18 法玛西雅厄普约翰美国公司 带有硫代羰基功能基的噁唑烷酮抗菌剂
GB9717807D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
JPH11322729A (ja) 1998-03-09 1999-11-24 Hokuriku Seiyaku Co Ltd ジチオカルバミド酸誘導体
GB9812019D0 (en) 1998-06-05 1998-07-29 Zeneca Ltd Chemical compounds
US6413981B1 (en) * 1999-08-12 2002-07-02 Ortho-Mcneil Pharamceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
US6608081B2 (en) 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods

Also Published As

Publication number Publication date
WO2003064415A1 (en) 2003-08-07
US6608081B2 (en) 2003-08-19
US20040067994A1 (en) 2004-04-08
MY134701A (en) 2007-12-31
CA2474718A1 (en) 2003-08-07
JP2005520815A (ja) 2005-07-14
EP1470123A1 (en) 2004-10-27
US6770664B2 (en) 2004-08-03
MXPA04007240A (es) 2005-03-31
TW200307679A (en) 2003-12-16
CN1642949A (zh) 2005-07-20
RU2004123097A (ru) 2006-01-20
BR0307259A (pt) 2004-12-07
US20020161029A1 (en) 2002-10-31
KR20040085167A (ko) 2004-10-07
PL371527A1 (en) 2005-06-27

Similar Documents

Publication Publication Date Title
AR038326A1 (es) Antibacterianos feniloxazolidinonas sustituidos con heterociclicos biciclicos y composiciones relacionadas y metodos
ES2515194T3 (es) Derivados de pirrolidina
ES2271615T3 (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados y su uso como antibacterianos.
AR053120A1 (es) Aminopiridinas como inhibidores de beta secretasa
ECSP067077A (es) Derivados de pirrolopiridina y su uso como antagonistas de crth2
PE20070189A1 (es) COMPUESTO DE AMINO-5-HETEROARILO (5 MIEMBROS) IMIDAZOLONA Y SU USO PARA MODULACION DE LA ß-SECRETASA
AR062677A1 (es) Derivados de biaril-sulfonamida, procesos de produccion y composiciones farmaceuticas que los comprenden
AR039868A1 (es) Inhibidores selectivos de la enzima kalikreina plasmatica
AR058554A1 (es) Compuestos heterociclicos nitrogenados de 6 miembros sustituidos, metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades mediadas por mglur5.
AR076460A1 (es) Antagonistas del receptor cxcr3
AR046200A1 (es) Derivados de pirazina y su uso farmaceutico. procesos de preparacion y composiciones farmaceuticas
AR063101A1 (es) Derivados de pirazina-2-carboxiamida, un proceso para su obtencion, composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos para el tratamiento o profilaxis de enfermedades asociadas con la modulacion de receptores del cb2.
AR063786A1 (es) Derivados de 1,4 -benzotiepina-1,1 dioxido sustituidos con radicales bencilo, productos farmaceuticos que comprenden estos compuestos y su uso
ES2531256T3 (es) Amidas fungicidas
CO5630023A2 (es) Fenil quinolinas y su uso como agentes estrogenicos
ECSP055974A (es) Síntesis de cloruros de 4 amino-2-butenoil y su uso en la preparación de 3-ciano quinolinas
CY1113450T1 (el) Διαμινοπυριμιδινες ως ρ2χ3 και ρ2χ2/3 ανταγωνιστες
CO5721002A2 (es) Derivados de acido 3-(4-benciloxifenil) propanoico
AR063601A1 (es) Arilamidas sustituidas por tiazol u oxazol
AR046394A1 (es) Derivados de quinolinas y quinazolinas, metodo de preparacion de los mismos y composiciones farmaceuticas que los contienen.
CO5690596A2 (es) Derivados de hexahidropirazino [1,2-a]pirimidin-4,7-diona sustituidos, en el nitrogeno, metodo para su produccion y su uso como medicamentos
UY30105A1 (es) Derivados nuevos azufrados de urea cíclica, su preparación y su utilización farmacéutica como inhibidores de quinasas.
CY1114932T1 (el) Αντιπαρασιτικοι παραγοντες
DOP2005000046A (es) Compuestos de acido alfa arilo o heteroaril metil beta piperidino propanoico como antagonistas del receptor orl1
PE20240886A1 (es) Compuestos espirociclicos

Legal Events

Date Code Title Description
FB Suspension of granting procedure